Provider Profile:
Ira Winer, M.D., Ph.D.

• Cervical Cancer
• Fallopian Tube Cancer
• Gestational Trophoblastic Disease
• Ovarian Cancer
• Uterine (Endometrial) Cancer
• Vaginal Cancer
• Vulvar Cancer

School

• University of Michigan Medical School

Residency

• University of Michigan Hospitals and Health Centers

Fellowships

• Wayne State University School of Medicine

Awards

• 2019 Hour Detroit Top Docs
• 2014 1st prize Research, Annual Wayne Day Presentation
• 2012 1st Prize in Fellow Research. Michigan Section ACOG Research Day oral presentation
• Graduated Cum Laude with MD, PhD and Distinction in research from University of Michigan Medical School
• Graduated Summa Cum Laude with Honors and Distinction in Major from Boston University
• Member of Phi Beta Kappa and Golden Key Honor Societies 

Professional Memberships

• American College of Obstetrics
• Gynecology Society of Gynecologic Oncology 

• Significance of lymphovascular space invasion in Uterine Serous Carcinoma- Extent or Presence? Int J Gynecol Pathol. 2015 Jan;34(1):47-56. PMID: 25473753 Winer I, Ahmed QF, Mert I, Bandyopadhyay S, Cote M, Munkarah AR, Hussein Y, Al-Wahab Z, Elshaikh MA, Alosh B, Schultz DS, Mahdi H, Nucci MR, Van de Vijver KK, Morris RT, Oliva E, Ali-Fehmi R.
  
• The prognostic significance of histologic type in early cervical cancer- A multi-Institutional Study. Gynecol Oncol. 2015 Jun;137(3):474-8. Epub 2015 Feb 10. PMID: 25677061Winer I, Alvarado-Cabrero I, Hassan O, Ahmed, QF, Alosh B, Bandyopadhyay S, Thomas S, Albayrak A, Talukdar S, Al-Wahab Z, Elshaikh M, Munkarah A, Morris R, Ali-Fehmi R.
  
• Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study. Gynecol Oncol. 2013 Feb;128(2):316-21. PMID: 23138135Winer I, Mahdi H, Bandyopadhyay S, Semaan A, Van de Vijver KK, Nucci MR, Abdul-Karim F, Hussein Y, Qureshi F, Hayek K, Alosh B, Schulz D, Cote M, Munkarah A, Morris R, Oliva E, Ali-Fehmi R.
  
• Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma. Cancer Metastasis Rev. 2015 Jan 18. PMID: 25597035Seward SM, Winer I.
  
• F3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivo. Cancer Res. 2010 Nov 1;70(21):8674-83. PMID: 20959470 Winer I, Wang S, Lee YE, Fan W, Gong Y, Burgos-Ojeda D, Spahlinger G, Kopelman R, Buckanovich RJ.